Lavender Callus Remover

Description

Lavender-gel is a topical formulation characterized by its gel dosage form. The product is designed for external application and is formulated to provide a soothing effect. Its appearance is consistent with a gel, which may exhibit a lavender hue, indicative of its lavender component. The specific composition and concentration of active ingredients contribute to its intended therapeutic effects.

Uses and Indications

This drug is indicated for the removal of corns and calluses. It provides relief from pain associated with these conditions by effectively removing the corns and calluses.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals should instruct patients to begin the treatment by soaking their feet in warm water for a duration of 10 to 15 minutes. Following the soak, the feet should be thoroughly dried using a clean towel.

Next, practitioners should advise the use of gloves during the application of the callus remover gel. The gel should be applied evenly to the affected areas and left on for an additional 10 to 15 minutes. After the designated time, it is essential to rinse off any residue from the gel to ensure complete removal.

Contraindications

Use is contraindicated in children under 2 years of age without the advice of a physician. This precaution is necessary to ensure safety and efficacy in this age group.

Warnings and Precautions

For external use only. It is imperative to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

This product is not recommended for use in children under the age of 2 unless directed by a healthcare professional.

Users should discontinue use immediately if any signs of irritation occur. Monitoring for adverse reactions is essential to ensure patient safety.

Side Effects

Patients should be advised that the product is for external use only. In the event of irritation, it is recommended to discontinue use immediately.

Drug Interactions

No drug interactions have been identified for the product, indicating that it does not have any known pharmacodynamic or pharmacokinetic interactions with other medications. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Lavender Callus Remover (salicylic acid 12%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under the age of 2 should not use this medication without the advice of a healthcare professional. It is essential to keep the product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center for guidance.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

There is no information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There are no specific statements or information regarding nursing mothers or lactation in the provided drug insert for Lavender Callus Remover (salicylic acid 12% gel). Therefore, the effects on lactating mothers and breastfed infants are not established. Healthcare professionals should exercise caution when recommending this product to lactating mothers, as the absence of data does not preclude potential risks.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that this product should not be used on children under the age of 2 without a doctor's advice. Patients should be counseled to stop using the product if any irritation occurs.

When using this product, patients should be instructed to wear gloves and limit the duration of use to 20 minutes. Caution should be exercised when using electric filing machines in conjunction with this product. Additionally, patients should avoid applying the product to broken or non-calloused skin.

Patients must be made aware to avoid contact with the eyes. In the event of eye contact, they should rinse the eyes for 15 minutes and consult a physician if irritation persists.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to ensure optimal stability. Once opened, the product should be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered topically and should be used with caution. Clinicians should advise patients to wear gloves during application and limit usage to 20 minutes. It is important to avoid application on broken or non-calloused skin and to prevent contact with the eyes; in the event of eye contact, patients should rinse for 15 minutes and seek medical advice if irritation persists. Patients should discontinue use if any irritation occurs and keep the product out of reach of children. In case of ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Lavender Callus Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)